Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 131

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling

Tsang, Hilda T.H., Edwards, Thomas L., Wang, Xinnan, Connell, James W., Davies, Rachel J., Durrington, Hannah J., O'Kane, Cahir J., Luzio, J. Paul, Reid, Evan·2009·Human Molecular Genetics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddp324

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 45

  1. Harding, 1993, Hereditary spastic paraplegias, Semin. Neurol., 13, 333, 10.1055/s-2008-1041143 · DOI
  2. Reid, 2003, Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias, J. Med. Genet., 40, 81, 10.1136/jmg.40.2.81 · DOI
  3. Soderblom, 2006, Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias, Pharmacol. Ther., 109, 42, 10.1016/j.pharmthera.2005.06.001 · DOI
  4. Fischer, 2004, Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man, Exp. Neurol., 185, 232, 10.1016/j.expneurol.2003.10.004 · DOI · Paper page
  5. Fink, 2006, Hereditary spastic paraplegia, Curr. Neurol. Neurosci. Rep., 6, 65, 10.1007/s11910-996-0011-1 · DOI · Paper page
  6. Hanein, 2008, Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome, Am. J. Hum. Genet., 82, 992, 10.1016/j.ajhg.2008.03.004 · DOI
  7. Hazan, 1999, Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia, Nat. Genet., 23, 296, 10.1038/15472 · DOI · Paper page
  8. Fonknechten, 2000, Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia, Hum. Mol. Genet., 9, 637, 10.1093/hmg/9.4.637 · DOI · Paper page
  9. Depienne, 2007, Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia, J. Med. Genet., 44, 281, 10.1136/jmg.2006.046425 · DOI
  10. Beetz, 2006, High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia, Neurology, 67, 1926, 10.1212/01.wnl.0000244413.49258.f5 · DOI
  11. Connell, 2009, Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion, Traffic, 10, 42, 10.1111/j.1600-0854.2008.00847.x · DOI
  12. Patel, 2002, SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia, Nat. Genet., 31, 347, 10.1038/ng937 · DOI · Paper page
  13. Bakowska, 2008, Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism?, Arch. Neurol., 65, 520, 10.1001/archneur.65.4.520 · DOI
  14. Bakowska, 2007, Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking, Mol. Biol. Cell., 18, 1683, 10.1091/mbc.E06-09-0833 · DOI
  15. Edwards, 2009, Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases API4 and AIP5, Biochem. J., 10.1042/BJ20082398 · DOI
  16. Beetz, 2008, Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots, J. Neurol. Sci., 268, 131, 10.1016/j.jns.2007.11.015 · DOI
  17. Goytain, 2007, NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter, J. Biol. Chem., 282, 8060, 10.1074/jbc.M610314200 · DOI
  18. Zhao, 2008, Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism, J. Neurosci., 28, 13938, 10.1523/JNEUROSCI.4668-08.2008 · DOI
  19. Wang, 2007, Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules, Nat. Neurosci., 10, 177, 10.1038/nn1841 · DOI · Paper page
  20. Keshishian, 2004, Orchestrating development and function: retrograde BMP signaling in the Drosophila nervous system, Trends Neurosci., 27, 143, 10.1016/j.tins.2004.01.004 · DOI
  21. O'Connor-Giles, 2008, Nervous wreck interacts with thickveins and the endocytic machinery to attenuate retrograde BMP signaling during synaptic growth, Neuron, 58, 507, 10.1016/j.neuron.2008.03.007 · DOI
  22. Cashman, 1992, Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons, Dev. Dyn., 194, 209, 10.1002/aja.1001940306 · DOI · Paper page
  23. Miyazono, 2005, BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk, Cytokine Growth Factor Rev., 16, 251, 10.1016/j.cytogfr.2005.01.009 · DOI · Paper page
  24. Korchynskyi, 2002, Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter, J. Biol. Chem., 277, 4883, 10.1074/jbc.M111023200 · DOI · Paper page
  25. Drose, 1993, Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases, Biochemistry, 32, 3902, 10.1021/bi00066a008 · DOI · Paper page
  26. Marciniak, 2006, Endoplasmic reticulum stress signaling in disease, Physiol. Rev., 86, 1133, 10.1152/physrev.00015.2006 · DOI · Paper page
  27. Melnick, 1992, The endoplasmic reticulum stress protein GRP94, in addition to BiP, associates with unassembled immunoglobulin chains, J. Biol. Chem., 267, 21303, 10.1016/S0021-9258(19)36608-6 · DOI
  28. Di Fiore, 2001, Endocytosis and signaling. An inseparable partnership, Cell, 106, 1, 10.1016/S0092-8674(01)00428-7 · DOI · Paper page
  29. Gonzalez-Gaitan, 2003, Endocytosis and signaling: a relationship under development, Cell, 115, 513, 10.1016/S0092-8674(03)00932-2 · DOI
  30. Polo, 2006, Endocytosis conducts the cell signaling orchestra, Cell, 124, 897, 10.1016/j.cell.2006.02.025 · DOI · Paper page
  31. Le Roy, 2005, Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling, Nat. Rev. Mol. Cell Biol., 6, 112, 10.1038/nrm1571 · DOI · Paper page
  32. Sweeney, 2002, Unrestricted synaptic growth in spinster—a late endosomal protein implicated in TGF-beta-mediated synaptic growth regulation, Neuron, 36, 403, 10.1016/S0896-6273(02)01014-0 · DOI
  33. Hartung, 2006, Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling, Mol. Cell. Biol., 26, 7791, 10.1128/MCB.00022-06 · DOI
  34. Shi, 2007, Endofin acts as a Smad anchor for receptor activation in BMP signaling, J. Cell Sci., 120, 1216, 10.1242/jcs.03400 · DOI
  35. Foletta, 2003, Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1, J. Cell Biol., 162, 1089, 10.1083/jcb.200212060 · DOI · Paper page
  36. Hassel, 2004, Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry, Proteomics, 4, 1346, 10.1002/pmic.200300770 · DOI
  37. Charron, 2007, The Hedgehog, TGF-beta/BMP and Wnt families of morphogens in axon guidance, Adv. Exp. Med. Biol., 621, 116, 10.1007/978-0-387-76715-4_9 · DOI
  38. Wen, 2007, BMP gradients steer nerve growth cones by a balancing act of LIM kinase and slingshot phosphatase on ADF/cofilin, J. Cell Biol., 178, 107, 10.1083/jcb.200703055 · DOI
  39. Lasorella, 2006, Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth, Nature, 442, 471, 10.1038/nature04895 · DOI · Paper page
  40. Matsuura, 2008, BMP inhibition enhances axonal growth and functional recovery after spinal cord injury, J. Neurochem., 105, 1471, 10.1111/j.1471-4159.2008.05251.x · DOI
  41. Reaves, 1996, The effect of wortmannin on the localisation of lysosomal type I integral membrane glycoproteins suggests a role for phosphoinositide 3-kinase activity in regulating membrane traffic late in the endocytic pathway, J. Cell Sci., 109, 749, 10.1242/jcs.109.4.749 · DOI
  42. Tiwari, 1987, Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors, EMBO J., 6, 3373, 10.1002/j.1460-2075.1987.tb02659.x · DOI
  43. Sanderson, 2006, Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners, Hum. Mol. Genet., 15, 307, 10.1093/hmg/ddi447 · DOI
  44. Motley, 2003, Clathrin-mediated endocytosis in AP-2-depleted cells, J. Cell Biol., 162, 909, 10.1083/jcb.200305145 · DOI · Paper page
  45. Reid, 2005, The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B, Hum. Mol. Genet., 14, 19, 10.1093/hmg/ddi003 · DOI

Cited by

See all 131

Metadata

Authors
Tsang, H. T. H., Edwards, T. L., Wang, X., Connell, J. W., Davies, R. J., Durrington, H. J., O'Kane, C. J., Luzio, J. P., & Reid, E.
Venue
Human Molecular Genetics
Published
2009-07-20
Volume
18
Issue
20
Pages
3805-3821
ISSN
  • 1460-2083
  • 0964-6906
Cited by
131
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. https://app.cochat.ai/papers/10.1093/hmg/ddp324
The paper
Tsang, H. T. H., Edwards, T. L., Wang, X., Connell, J. W., Davies, R. J., Durrington, H. J., O'Kane, C. J., Luzio, J. P., & Reid, E. (2009). The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddp324

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.